Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.6.1.1 (
adenylate cyclase
)
19,190
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In mice X-irradiated with doses of 200 R and 400 R, there was a substantial increase in spleen
adenyl cyclase
activity; there was similar activation by
MEA
. In mice given
MEA
before irradiation, an additive effect of radiation and the radioprotective drug was observed. On the other hand, a dose of 800 R given either alone or after pre-treatment with
MEA
failed to elicit any change in cyclase activity. The results indicate the importance of the
adenyl cyclase
system in the response of cells to irradiation and action of
MEA
.
...
PMID:Effects of ionizing radiation and cysteamine (MEA) on activity of mouse spleen adenyl cyclase. 108 63
Aminothiol radioprotectors (
MEA
, AET, WR-1065) were found to be inhibitors of platelet aggregation. The aim of this study has been to clarify the potential involvement of the
adenylate cyclase
-cAMP system in this effect. In vitro aminothiol compounds (> 1 mmol/l) inhibited platelet function as well as AC-activity, i.e. significantly reduced their cAMP content. In less than 1 mmol/l concentration WR-1065 elevated the cAMP content of PGI2-stimulated platelets, while basal cAMP level mainly remained unchanged. On the effect of WR-1065 the level of non-protein thiols (NP-SH) markedly elevated in the platelets, while their protein-bound thiol content (PB-SH) either decreased or remained at control level. The phosphorothioate WR-2721 was effective only after in vitro or in vivo dephosphorylation. Although the amount of NP-SH slightly increased, the PB-SH content decreased in the platelets isolated after intravenous administration of WR-2721. Moreover, platelet-poor plasma samples of WR-2721 treated animals also inhibited both the AC-activity and function of control platelets, too. Based on these results it is suggested that aminothiol radioprotectors non-specifically inhibit platelet functions forming mixed disulfides with endogenous, mostly protein-bound thiols. The slight elevation of AC-activity caused by low doses of WR-1065 also suggest that the AC-complex consists of unevenly sensitive subunits (G-proteins, catalytic subunit).
...
PMID:Effect of radioprotectors on the aggregability, cAMP and thiol content of blood platelets. 886 1